U.S. market Closed. Opens in 1 day 6 hours 32 minutes

BIO | Bio-Rad Laboratories, Inc. Stock Overview

(Stock Exchange: NYSE)
Day's Range 325.72 - 334.10
52 Week Range 262.12 - 387.99
Beta 0.89
Implied Volatility 39.91%
IV Rank 34.72%
Day's Volume 157,239
Average Volume 193,490
Shares Outstanding 28,035,690
Market Cap 9,180,847,404
Sector Healthcare
Industry Medical - Devices
IPO Date 1980-02-27
Valuation
Profitability
Growth
Health
P/E Ratio -11.65
Forward P/E Ratio N/A
EPS -28.10
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 7,700
Country USA
Website BIO
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
BIO's peers: TNDM, DXCM, INSP, SWAV, PEN, CNMD, BRKR, ZBH, GKOS, NARI, PODD, GMED, NVCR, STE, ANIK, ITGR, CTLT, PHG
*Chart delayed
Analyzing fundamentals for BIO we got that it has weak fundamentals where Valuation is considered to be fairly valued, Profitability is unacceptably poor, Growth is good and Health is very strong. For more detailed analysis please see BIO Fundamentals page.

Watching at BIO technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on BIO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙